Ontology highlight
ABSTRACT:
SUBMITTER: Levitin M
PROVIDER: S-EPMC7539115 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
Frontiers in oncology 20200923
Renal cell carcinoma (RCC) comprises 4.2% of all new cancer cases in the United States and 30% of cases are metastatic (mRCC) at diagnosis. Brain metastatic RCC historically has poor prognosis, but the development of immune checkpoint inhibitors has revolutionized their care and may be successfully combined with SBRT to improve prognosis. Here, we present a case of a patient with mRCC who had brain metastases treated with concurrent immune checkpoint inhibitors and SBRT. He continues to survive ...[more]